The CYMEDSEC Consortium will be represented by Medisanté at the Hypertension Days (Journées de l’Hypertension Artérielle – JHTA) in Paris on December 19–20, 2024. This premier event is expected to attract more than a thousand cardiologists and healthcare leaders.
A booth will feature CYMEDSEC branding and emphasizes the crucial importance of cybersecure, multi-vendor IoT fleet management for large-scale hospital-at-home initiatives across Europe. It is a key opportunity for live demonstrations, industry engagement, and dissemination of key findings from the project. Fighting hypertension begins with a seamless and secure telehealth IoT data collection from patients at home.
In particular, during the event, it will be showcased how Medisanté’s Internet of Medical Things (IoMT) solutions supported George Medicines in collecting 500.000 blood pressure readings during their GMRx2 global phase III trial. As single-pill combinations become the new frontier in hypertension management, we encourage you to join the session – on December 19th at 2 PM CET – featuring renowned experts such as Prof. Anthony Rodgers to delve into the latest developments:
The Hypertension Days (JHTA) present a significant opportunity for CYMEDSEC and Medisanté to showcase how their partnership drives innovation at the intersection of IoMT, cardiology, and clinical research.
For further information please visit JHTA website:
To schedule a meeting during JHTA, please contact:
Gilles Lunzenfichter, CEO, Medisanté
gilles.lunzenfichter@medisante-group.com
About Medisanté: Medisanté enables the hospital-at-home with global cellular IoT. By connecting and managing home medtech devices over a global private cellular network—rather than relying on patients’ smartphones—it radically simplifies telehealth IoT data collection, especially for elderly chronic patients. Medisanté Hub (M+ Hub) is the first multi-vendor telehealth device cloud with no patient personally identifiable information (PII). It connects and manages out-of-the-box devices “powered by Medisanté” from trusted vendors such as Beurer, Foracare, and Transtek Medical. The platform integrates effortlessly into any health IT system, where care teams assign devices to patients. By leveraging best-in-class global technologies and reliable last mile logistics—including for telehealth gateways—Medisanté allows remote patient monitoring (RPM) and decentralized clinical trials (DCT) to scale with no compromise on security, privacy, or inclusion. See https://www.medisante-group.com/
Image: courtesy of JHTA